Two new secondary metabolites, aranorosinol A (1) and aranorosinol B (2), were isolated from a strain of Pseudoarachniotus roseus. Their structures were elucidated on the basis of their spectral properties and chemical transformations and were found to be similar to aranorosin (3) isolated from the samestrain.
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We have recently isolated two new metabolites, aranorosinol A (1) and aranorosinol B (2) , from the fungal strain Y-30499 identified as Pseudoarachniotus roseus. Herein we report the isolation, structure elucidation and biological properties of these two metabolites. Compounds1 and 2 are structurally related to aranorosin (3) which was isolated earlier from the same fungal strain1~3).
Fermentation
Fermentation was carried out in shake flasks as well as in laboratory fermenters using the methods and conditions reported earlierX). The progress of the fermentation was monitored by the agar diffusion assay using Bacillus subtilis as the test strain. The antibiotics were present in both the culture filtrate and the mycelial cake.
Isolation
The culture filtrate (40 liters) was extracted with ethyl acetate (2 x 15 liters). The mycelial cake (3.7 kg) Dedicated to Prof. Ch. Bheemasankara Rao of Andhra University on the occasion of his 60th birthday. was extracted with acetone (2 x 8 liters). The combined acetone extracts were concentrated under reduced pressure, diluted with water and extracted with ethyl acetate (2 x 750ml). These ethyl acetate extracts of mycelial cake were combinedwith those of the culture filtrate and concentrated under reduced pressure to give 18.7g of the crude antibiotic mixture as a reddish brownsyrupy material. This was flash chromatographed on silica gel (230~400 mesh, 250 g, flow rate: 50ml/minute) using CHC13 and a gradient of MeOHin steps of 1% for elution. A mixture of aranorosinol B (2) and aranorosin (3) was eluted with 2-3% MeOHin CHC13, while aranorosinol A (1) was eluted with 5% MeOHin CHC13. The semipure aranorosinol A (1) (3.7 g) was flash chromatographed on silica gel (230~400mesh, 60g) with a flow rate of 40ml/minute using CHC13-MeOH(95 : 5) as the eluent. The active eluates were evaporated to dryness under reduced pressure, dissolved in CHC13 and pure aranorosinol A (1) was precipitated as a white solid (1.2g) by adding hexane. The mixture (3.6g) of aranorosinol B (2) and aranorosin (3) was separated on a silica gel (230-400mesh, 150g) column using petroleum ether (60 -70°C) -ethyl acetate mixtures for elution. Pure aranorosin (3) was eluted with petroleum ether -ethyl acetate (1 : 1), while aranorosinol B (2) was eluted with petroleum ether-ethyl acetate (1 : 3). The eluates containing 2 were evaporated to dryness, dissolved in CHC13and precipitated with hexane to give pure aranorosinol B as a white solid (40mg).
The physico-chemical characteristics ofaranorosinol A (1) and aranorosinol B (2) are listed in Table 1 . Structure Elucidation The *H and 13C NMRdata of aranorosinol A (1) and aranorosinol B (2) are listed in Table 2 . A comparison of the 1H and 13C NMRspectra of aranorosinol A (1) and aranorosinol B (2) with those of aranorosin (3)2'3) showed close structural similarity of the compounds;all three compoundshad the same fatty acid side chain (4,6-dimethyldodeca-2£',4JE-dienoyl moiety) and the same l -oxaspiro [4. 5] decane ring system. Structural differences between 1, 2 and 3 were observed at the C-8 position only.
Aranorosinol A (1) Aranorosinol A (1), C23H35NO6, differs from 3 in having two additional hydrogens in the molecule. Spectra were taken at 22.5 MHzusing 50mg/ml concentrations and the assignments of 1 and 2 were based on comparison with those reported for aranorosin (3). Spectra were taken at 300MHzusing lOmg/ml concentrations.
CDC13.
CDC13-C6D6 (3: 1).
CDC13-CD3OD (8 :2).
These chemical shifts were obtained from *H NMRspectrum taken in DMSO-d6.
The XHNMRspectrum shows three D2Oexchangeable protons (d 6.74, 6.63 and 5.43) as compared to the presence of two D2Oexchangeable protons in 3. This observation gave an early indication that 1 might be a reduced form of 3. The 13C NMRdata of 1 showed the absence of the C-8 carbonyl group of 3 and the presence of a new signal at S 64.15 (-CH(O)/DEPT-135). In the *H NMRspectrum, this oxymethine proton appeared at S 4.28 (t, /=2.7 Hz). Acetylation of 1 with acetic anhydride -pyridine gave a diacetate (4) Furthermore, NOESY cross-peaks were observed between the H-8 proton and the epoxy protons indicating their proximal orientation, but the exact relative configuration at C-8 remains uncertain. Aranorosinol B (2) As in the case of 1, aranorosinol B (2), C26H39NO7, had three D2O exchangeable protons (<56.20, 5.54 and 4.69), an oxygenated carbon signal at S66.42 in the 13C NMRspectrum and lacked the C-8 carbonyl group of 3. In the 13C NMRspectrum of 2, three additional carbons appeared at (5210.44 (carbonyl group), (547.45 (CH2/DEPT-135) and 5 31.53 (CH3/DEPT-135). The CH2 and CH3 groups were isolated spin systems and appeared as singlets in the *H NMRspectrum at (5 3.07 and (5 2.28, respectively. The above data are best explained by an 8-C(OH)CH2COCH3 moiety. The presence of such a group is knownfrom the enaminomycins5).
Aranorosinol B (2) underwent monoacetylation with acetic anhydride -pyridine (1.5 equiv, 24 hours at ambient temperature) to give 6, C28H41NO8. It was characterised by the IR spectrum (1755cm"1, O-acetyl) and the deshielding of the H-2 proton from d5.56 to 6.41 in the 1H NMRspectrum. However, with excess of acetic anhydride -pyridine (5 equiv, 24 hours at ambient temperature) a mixture of 6 and a diacetate (7), in which the 8-hydroxyl group was also acetylated, was formed. These could be separated on a silica gel column (230~400mesh) using CHC13-MeOHmixtures for elution.
The proposed structure of 2 had a /?-hydroxycarbonyl group which was appropriate for a retroaldol condensation to give 3. Reaction of 2 with butylamine (20 equiv) in DMSO(3 hours at ambient temperature) indeed gave a product which was identical to 3 by MP, TLC, IR, lH and 13C NMR, thus establishing the structural relationships between 2 and 3. A 2D^H COSYspectrum of2 further confirmed the proton connectivities and the structure ofaranorosinol B was thus established to be 2. Stereochemistry of 2: Chemical conversion of 2 to 3 established the spatial relationships of the various protons in 2 to be the same as in 3 except at C-8. 2D NOESY and difference NOEexperiments further supported this. NOESY cross-peaks were observed between the methylene protons H-l" and the epoxy protons H-7 and H-9 indicating that the 8-CH2COCH3 group should be oriented close to the epoxy protons in the most favoured conformer of 2. However, the relative stereochemistry of the groups at C-8 remains uncertain.
Biological Properties
The minimum inhibitory concentrations (MIC) of aranorosinol A (1) and aranorosinol B (2) required to inhibit a variety of bacterial and fungal strains are listed in Table 3 . Both 1 and 2 possess only weak antibacterial and antifungal properties.
Experimental
UVspectra were recorded on a UVIKON 810 double beamspectrophotometer. IR spectra were taken on a Perkin-Elmer 1 57 spectrophotometer. Mass spectra were recorded on a Kratos MS9025 spectrometer. Optical rotations were measured using a Perkin-Elmer 141 polarimeter. NMRspectra were recorded on Jeol FX90Q, Varian VXR300 and Bruker ACP 300 instruments.
DEPT, COSY and NOESYspectra were recorded using standard parameters. A mixing time of 500 milliseconds and lOmmol solutions of 1 and 2 in CDC13-CD3ODand CDC13respectively were used for recording the NOESYspectrum. TLCs were carried out using pre-coated silica gel plates from E. Merck (for preparative TLC, Article No. 13794; for analytical TLC, Article No. 5554).
Aranorosinol A Diacetate (4) (1) (50mg, To aranorosinol A 0.12mmol), acetic anhydride (0.1 ml, 1.06mmol) and pyridine (0.1 ml, 1.24mmol) were added and the mixture kept at room temperature for 16 hours. The crude diacetate (50mg), obtained on usual work up, was purified by silica gel column chromatography (230~400mesh, 5g) using CHCl3-MeOH mixtures for elution. The semi-pure diacetate was eluted with 1% MeOHin CHC13and was further purified by preparative TLC using CHC13 -MeOH(95 : 5) for developing the plates. Pure aranorosinol A diacetate (4) Oxidation of Aranorosinol A (1) to the Ketolactone (5) To aranorosinol A (1) (300mg, 0.71 mmol) in acetone (10ml), Jones reagent4) (14ml) was added slowly at roomtemperature over a period of 1 hour till the colour of the reagent persisted. The reaction mixture was then poured into ice water (50ml) and extracted with CH2C12(3 x25ml). The combined CH2C12extracts were dried over Na2SO4and evaporated under reduced pressure. The crude product (138mg) was purified by preparative TLC using MeOH-CH2C12 (10 : 90) for developing the plates. The pure product (95 mg) was identical to the ketolactone (5) derived from the oxidation of aranorosin (3)2) by TLC, MP, IR, XH and 13C NMRspectra.
Reduction of Aranorosin (3) to Aranorosinol A (1) To aranorosin (3) (lOOmg, 0.24mmol) in THF (5ml), sodium borohydride (9.4mg, 0.25mmol) was Aranorosinol B Diacetate (7)
To aranorosinol B (2) (150mg, 0.31 mmol), pyridine (0.2ml, 2.47mmol) and acetic anhydride (0.3 ml, 3.18mmol) were added and the mixture kept at room temperature for 24 hours. The crude product, obtained on usual work up, was a mixture of mono-and di-acetates which was separated by silica gel column chromatography (230~400mesh) using CHC13-MeOHmixtures for elution.
The diacetate (7), eluted with 0.5% MeOHin CHC13,was obtained as a white solid from CHC13-hexane mixture. Yield 40mg; MP 85~88°C; TLC Rf 0.6 (solvent CHCl3-MeOH (95 : 5)); molecular formula C30H43NO9; CI-MS m/z 562 (M+H)+; UV Amax (MeOH)nm 264; IR (KBr) cm"1 3500, 3400, 3280, 2960,
